Anti Parietal Cell Antibodies (APCA) with titer by IFA

Anti Parietal Cell Antibodies (APCA) with Titer by IFA

Overview

The Anti Parietal Cell Antibodies (APCA) with Titer by Indirect Immunofluorescence Assay (IFA) test detects autoantibodies directed against gastric parietal cells. These antibodies are commonly associated with autoimmune gastritis and pernicious anemia, conditions that can impair vitamin B12 absorption and lead to anemia and neurological complications.

Why is this Test Done?

Your doctor may recommend this test to:

• Diagnose autoimmune gastritis.
• Evaluate the cause of vitamin B12 deficiency.
• Investigate pernicious anemia.
• Assess unexplained macrocytic anemia.
• Support the diagnosis of autoimmune disorders affecting the stomach.
• Monitor patients at risk for autoimmune gastric disease.

Symptoms That May Require Testing

• Persistent fatigue or weakness
• Pale skin
• Numbness or tingling in hands and feet
• Difficulty walking or balance problems
• Memory loss or confusion
• Sore, smooth tongue (glossitis)
• Loss of appetite
• Abdominal discomfort or indigestion

Test Method

• Sample: Serum (Blood)
• Method: Indirect Immunofluorescence Assay (IFA)
• Result: Antibody detected with titer (antibody concentration), providing information on the strength of the immune response.

Preparation

• No special fasting is generally required.
• Inform your healthcare provider about any medications or autoimmune conditions.

Understanding the Results

• Negative: No significant anti-parietal cell antibodies detected.
• Positive (Low Titer): May indicate early or mild autoimmune gastric disease.
• Positive (High Titer): Strongly suggests autoimmune gastritis or pernicious anemia and may require additional testing, such as:
  • Vitamin B12
  • Intrinsic Factor Antibody
  • Complete Blood Count (CBC)
  • Serum Gastrin
  • Iron Studies

Who Should Consider This Test?

• Individuals with unexplained vitamin B12 deficiency
• Patients with macrocytic anemia
• People with suspected autoimmune gastritis
• Individuals with other autoimmune disorders (e.g., thyroid disease, type 1 diabetes)
• Patients with a family history of autoimmune diseases

Benefits

• Early detection of autoimmune gastric disorders
• Helps diagnose pernicious anemia
• Supports timely vitamin B12 treatment
• Reduces the risk of neurological complications
• Assists physicians in planning further evaluation and management

Note: APCA positivity alone does not confirm a diagnosis. Results should always be interpreted alongside clinical findings and other laboratory investigations by a qualified healthcare professional.